Profiel
Wayne Saville worked as Vice President-Clinical Oncology at Xencor, Inc. from 2015 to 2020.
He also worked as Vice President-Clinical Development at Tocagen, Inc. Dr. Saville received his undergraduate and doctorate degrees from Northwestern University.
Eerdere bekende functies van Wayne Saville
| Bedrijven | Functie | Einde |
|---|---|---|
| XENCOR, INC. | Corporate Officer/Principal | 01-04-2020 |
| FORTE BIOSCIENCES, INC. | Corporate Officer/Principal | - |
Opleiding van Wayne Saville
| Northwestern University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| XENCOR, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Tocagen, Inc.
 Tocagen, Inc. BiotechnologyHealth Technology Tocagen, Inc. is a clinical-stage, cancer-selective gene therapy company, which engages in the development of product candidates designed to activate a patient's immune system against their own cancer. It is in the business of discovery, development, and commercialization of products for the treatment of cancer. The company was founded by Thomas E. Darcy, Harry E. Gruber, Douglas J. Jolly, and Dennis N. Berman in August 2007 and is headquartered San Diego, CA. | Health Technology |